I have been using BioGlue since its market introduction almost 10 years ago, said Dr. John W. Fehrenbacher, Methodist Hospital, Indianapolis, Ind. I have utilized BioGlue in over 1,000 patients undergoing a variety of cardiac procedures including valve replacements, aneurysm repair, and aortic dissection repair. I find that BioGlue is safe, easy to use, and because of its effectiveness at reducing anastomotic bleeding, has allowed me to change the way I perform many of my aortic aneurysm procedures.

Irrespective of the body’s clotting mechanism, BioGlue creates flexible, and mechanical seal. It comes in a self-contained, disposable syringe that is available in 2mL, 5mL, and 10mL volumes.

The use of BioGlue has continued to grow as surgeons around the globe have experienced its highly effective sealing properties during complex procedures, said Steven G. Anderson, president and CEO of CryoLife. We anticipate the continued adoption of BioGlue as an essential component of the surgical toolkit, particularly as it is approved for additional indications.

US Food and Drug Administration has approved BioGlue as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. It is used most commonly in the US for complex cardiovascular procedures involving valve replacements, aortic dissections and aortic aneurysms, as well as peripheral vascular procedures, such as carotid endarterectomy, and arteriovenous access.

The BioGlue is indicated for use in vascular and cardiac procedures as well as for repair of other soft tissues, including pulmonary, genitourinary, dural, esophageal, gastrointestinal, and colorectal, and other abdominal tissues (pancreatic, splenic, hepatic, biliary). Surgical meshes in hernia repair are also fixed with BioGlue.